Results 161 to 170 of about 2,105 (191)

Índex de gèneres, espècies, subespècies i noms comuns [PDF]

, 2013
,
core  

Some of the next articles are maybe not open access.

Related searches:

Myiopsitta monachus subsp. calita

2021
Myiopsitta monachus calita (Cotorra) R. Residente. D. Toda la provincia (Nores et al., 1991; López de Casenave et al., 1998; Codesido y Bilenca, 2004; Aparicio et al., 2008; Heredia, 2011; Coria, 2012a, b; Coria et al., 2015a, b, 2016, 2017). C. No Amenazada.
Coria, Oscar R., Quiroga, Oscar B., Navarro, José L., Heredia, Javier, Torres, Ricardo, Lima, Javier   +5 more
openaire   +1 more source

Clinical ophthalmic parameters of the Quaker parrot (Myiopsitta monachus)

Veterinary Ophthalmology, 2022
AbstractPurposeOphthalmic diagnosis in many avian species remains hindered by a lack of normative values. This study aimed to establish normal ophthalmic parameters for select diagnostic tests in clinically normal Quaker parrots.MethodsNinety‐six captive Quaker parrots aged 8–18 years underwent ophthalmic examination to include assessment of neuro ...
Emily L. Halsmer, Jennifer Jill Heatley, Erin M. Scott   +2 more
openaire   +2 more sources

Argas (Argas) Monachus, New Species (Ixodoidea: Argasidae), from Nests of the Monk Parakeet, Myiopsitta Monachus, in Argentina1

Journal of Medical Entomology, 1973
James E. Keirans, Frank J. Radovsky, Carleton M. Clifford   +2 more
openaire   +3 more sources

Acyclovir (Zovirax®) pharmacokinetics in Quaker parakeets,Myiopsitta monachus

Journal of Veterinary Pharmacology and Therapeutics, 1992
The pharmacokinetics of intravenous (i.v.) and intramuscular (i.m.) single‐dose administration of acyclovir were determined in Quaker parakeets. After i.v. injection at a dose of 20 mg/kg of acyclovir, elimination half‐life was estimated at 0.65 h, volume of distribution at steady state was 627.65 ml/kg, and clearance was 11.22 ml/kg/min. The estimated
T M, Norton, G V, Kollias, C H, Clark, J, Gaskin, R C, Wilson, J, Coniglario   +5 more
openaire   +2 more sources

Myiopsitta monachus subsp. monachus

2017
Published as part of Pagano, Luis G. & Salvador, Sergio A., 2017, Datos De Pesos De Aves Argentinas. Parte 4, pp.
Pagano, Luis G., Salvador, Sergio A.
openaire   +1 more source

The Use of Alfaxalone in Quaker Parrots (Myiopsitta monachus)

Journal of Avian Medicine and Surgery, 2019
Alfaxalone is a neurosteroid anesthetic that acts on gamma-aminobutyric acid alpha-receptors. The objective of this study was to evaluate the clinical safety and efficacy of alfaxalone (Alfaxan CD). Due to observed hyperexcitability in the subject animals when alfaxalone was the only drug used during the initial trials, premedication with midazolam was
Michelle C, Whitehead, Sharman M, Hoppes, Jeffrey M B, Musser, Jennifer L, Perkins, Mauricio L, Lepiz   +4 more
openaire   +2 more sources

Lipid-Related Lesions in Quaker Parrots (Myiopsitta monachus)

Veterinary Pathology, 2018
The Quaker parrot has been used as a psittacine model to study clinical lipidology and lipid-related disorders. However, while Quaker parrots appear to be anecdotally susceptible to a variety of spontaneous dyslipidemic disorders and lesions caused by excess lipid accumulation, epidemiologic data are lacking.
Hugues Beaufrère, Drury Reavill, Jill Heatley, Leonardo Susta   +3 more
openaire   +2 more sources

Experimental Diet-Induced Atherosclerosis in Quaker Parrots (Myiopsitta monachus)

Veterinary Pathology, 2013
Spontaneous atherosclerosis is common in psittaciformes, and clinical signs associated with flow-limiting stenosis are encountered in pet birds. Nevertheless, a psittacine model of atherosclerosis has not been developed for research investigations. Sixteen captive-bred Quaker parrots ( Myiopsitta monachus) were used in this study.
H, Beaufrère, J G, Nevarez, N, Wakamatsu, S, Clubb, C, Cray, T N, Tully   +5 more
openaire   +2 more sources